Kunal B Desai (Kunal Desai)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Metastatic Renal Cell Carcinoma

Prognostic Factors

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Targeted oncology

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A phase I trial of enzalutamide plus selective glucocorticoid receptor modulator relacorilant in patients with metastatic castration resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Kunal B Desai, Anthony V Serritella, Walter M Stadler, Peter H O'Donnell, Randy F Sweis, Russell Zelig Szmulewitz
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Landon C Brown, Kunal B Desai, Tian Zhang, Moshe C Ornstein
The Immunotherapy Landscape in Renal Cell Carcinoma. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 34 (6) (2021)
Kunal B Desai, Landon C Brown, Wei Wei, Matthew D Tucker, Chester Kao, Emily Kinsey, Brian Rini, Kathryn E Beckermann, Tian Zhang, Moshe C Ornstein
A Multi-institutional, Retrospective Analysis of Patients with Metastatic Renal Cell Carcinoma to Bone Treated with Combination Ipilimumab and Nivolumab. Targeted oncology 16 (5) (2021)
Kunal B Desai, Anne Hubben, Manmeet Ahluwalia
The Role of Checkpoint Inhibitors in Glioblastoma. Targeted oncology 14 (4) (2020)